Rheumatology and therapy.
Rheumatology and Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3-4 weeks from acceptance). The journal is dedicated to the publication of high-quality preclinical, clinical (all phases), observational, real-world, and health out...
Saved in:
VerfasserIn: | |
---|---|
Place / Publishing House: | [London] : : Springer Healthcare,, [2014]- |
Publication history: | Began with Volume 1, Issue 1 (December 2014). |
Language: | English |
Physical Description: | 1 online resource |
Notes: | Refereed/Peer-reviewed |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993574739304498 |
---|---|
lccn |
2016243015 |
ctrlnum |
(DE-599)ZDB2783278-8 (OCoLC)890026801 (CKB)3710000000219340 (CONSER)--2016243015 (NjHacI)993710000000219340 (EXLCZ)993710000000219340 |
collection |
bib_alma |
record_format |
marc |
spelling |
Springer Healthcare, author, issuing body. RHEUMATOL THER Rheumatol. ther. Rheumatology and therapy. [London] : Springer Healthcare, [2014]- 1 online resource Two issues a year, 2015- text txt rdacontent computer c rdamedia online resource cr rdacarrier Began with Volume 1, Issue 1 (December 2014). Refereed/Peer-reviewed Unrestricted online access star Numbering from content page. Volume 1 complete in 1 issue. Rheumatology and Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3-4 weeks from acceptance). The journal is dedicated to the publication of high-quality preclinical, clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of rheumatologic therapies. Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also encouraged. Description based on Volume 1, Issue 1 (December 2014); title from journal homepage (publisher's website, viewed December 4, 2015). Latest issue consulted: Volume 2, Issue 2 (December 2015) (viewed January 8, 2016). Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis -- Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid Arthritis -- Current Practice Patterns and Educational Needs of Rheumatologists Who Manage Patients with Rheumatoid Arthritis -- Mannitol Preserves the Viscoelastic Properties of Hyaluronic Acid in an In Vitro Model of Oxidative Stress. Rheumatology. fast (OCoLC)fst01097048 Physical and Rehabilitation Medicine. Rheumatology. Rheumatic Diseases. Rheumatism Physical therapy Periodicals. Rheumatology Periodicals. Periodical. Periodicals. fast (OCoLC)fst01411641 2198-6576 |
language |
English |
format |
Journal |
author_corporate |
Springer Healthcare, |
author_facet |
Springer Healthcare, |
author_corporate_role |
VerfasserIn |
author_sort |
Springer Healthcare, |
title |
Rheumatology and therapy. |
spellingShingle |
Rheumatology and therapy. Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis -- Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid Arthritis -- Current Practice Patterns and Educational Needs of Rheumatologists Who Manage Patients with Rheumatoid Arthritis -- Mannitol Preserves the Viscoelastic Properties of Hyaluronic Acid in an In Vitro Model of Oxidative Stress. |
title_short |
RHEUMATOL THER |
title_full |
Rheumatology and therapy. |
title_fullStr |
Rheumatology and therapy. |
title_full_unstemmed |
Rheumatology and therapy. |
title_auth |
Rheumatology and therapy. |
title_new |
Rheumatology and therapy. |
title_sort |
rheumatology and therapy. |
publisher |
Springer Healthcare, |
publishDate |
2014 |
physical |
1 online resource |
dateSpan |
Began with Volume 1, Issue 1 (December 2014). |
contents |
Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis -- Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid Arthritis -- Current Practice Patterns and Educational Needs of Rheumatologists Who Manage Patients with Rheumatoid Arthritis -- Mannitol Preserves the Viscoelastic Properties of Hyaluronic Acid in an In Vitro Model of Oxidative Stress. |
issn |
2198-6584 2198-6576 |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC925 |
callnumber-sort |
RC 3925 A1 S675 42014 |
genre |
Periodical. Periodicals. fast (OCoLC)fst01411641 |
genre_facet |
Periodicals. Periodical. |
illustrated |
Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.74 |
dewey-sort |
3616.74 |
dewey-raw |
616.74 |
dewey-search |
616.74 |
oclc_num |
890026801 |
work_keys_str_mv |
AT springerhealthcare rheumatologyandtherapy |
status_str |
n |
ids_txt_mv |
(DE-599)ZDB2783278-8 (OCoLC)890026801 (CKB)3710000000219340 (CONSER)--2016243015 (NjHacI)993710000000219340 (EXLCZ)993710000000219340 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Rheumatology and therapy. |
_version_ |
1796652617904947201 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nas-a2200565-i-4500</leader><controlfield tag="001">993574739304498</controlfield><controlfield tag="005">20240119213020.0</controlfield><controlfield tag="006">m-----o--d--------</controlfield><controlfield tag="007">cr-|||||||||||</controlfield><controlfield tag="008">140901c20149999enk||-poo-----0----0eng-c</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a"> 2016243015</subfield></datafield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">GBB5E7656</subfield><subfield code="2">bnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">101674543</subfield><subfield code="2">DNLM</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">2783278-8</subfield><subfield code="2">DE-600</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1056993626</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">017575480</subfield><subfield code="2">Uk</subfield></datafield><datafield tag="022" ind1=" " ind2=" "><subfield code="a">2198-6584</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)ZDB2783278-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)890026801</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)3710000000219340</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CONSER)--2016243015</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)993710000000219340</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)993710000000219340</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="042" ind1=" " ind2=" "><subfield code="a">pcc</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC925.A1</subfield><subfield code="b">.S675 2014</subfield></datafield><datafield tag="060" ind1="0" ind2="0"><subfield code="a">W1</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.74</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.83</subfield><subfield code="2">bcl</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">Springer Healthcare,</subfield><subfield code="e">author,</subfield><subfield code="e">issuing body.</subfield></datafield><datafield tag="210" ind1=" " ind2=" "><subfield code="a">RHEUMATOL THER</subfield></datafield><datafield tag="210" ind1="0" ind2=" "><subfield code="a">Rheumatol. ther.</subfield></datafield><datafield tag="222" ind1=" " ind2="0"><subfield code="a">Rheumatology and therapy.</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Rheumatology and therapy.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[London] :</subfield><subfield code="b">Springer Healthcare,</subfield><subfield code="c">[2014]-</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="310" ind1=" " ind2=" "><subfield code="a">Two issues a year,</subfield><subfield code="b">2015-</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="362" ind1="1" ind2=" "><subfield code="a">Began with Volume 1, Issue 1 (December 2014).</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Refereed/Peer-reviewed</subfield></datafield><datafield tag="506" ind1="0" ind2=" "><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="515" ind1=" " ind2=" "><subfield code="a">Numbering from content page.</subfield></datafield><datafield tag="515" ind1=" " ind2=" "><subfield code="a">Volume 1 complete in 1 issue.</subfield></datafield><datafield tag="520" ind1="0" ind2=" "><subfield code="a">Rheumatology and Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3-4 weeks from acceptance). The journal is dedicated to the publication of high-quality preclinical, clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of rheumatologic therapies. Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also encouraged.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on Volume 1, Issue 1 (December 2014); title from journal homepage (publisher's website, viewed December 4, 2015).</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Latest issue consulted: Volume 2, Issue 2 (December 2015) (viewed January 8, 2016).</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis -- Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid Arthritis -- Current Practice Patterns and Educational Needs of Rheumatologists Who Manage Patients with Rheumatoid Arthritis -- Mannitol Preserves the Viscoelastic Properties of Hyaluronic Acid in an In Vitro Model of Oxidative Stress.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Rheumatology.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst01097048</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Physical and Rehabilitation Medicine.</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Rheumatology.</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Rheumatic Diseases.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Rheumatism</subfield><subfield code="x">Physical therapy</subfield><subfield code="v">Periodicals.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Rheumatology</subfield><subfield code="v">Periodicals.</subfield></datafield><datafield tag="655" ind1=" " ind2="2"><subfield code="a">Periodical.</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Periodicals.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst01411641</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="x">2198-6576</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">JOURNAL</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-03-01 01:46:08 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2014-08-10 02:12:22 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAJ Directory of Open Access Journals</subfield><subfield code="P">DOAJ Directory of Open Access Journals</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5342031920004498&Force_direct=true</subfield><subfield code="Z">5342031920004498</subfield><subfield code="m"> Available from 2014.</subfield><subfield code="b">Available</subfield><subfield code="8">5342031920004498</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="Z">5342031920004498</subfield><subfield code="A">2014</subfield></datafield></record></collection> |